Rozanolixizumab self-administration was 100% successful, with patients preferring the manual push method over infusion pumps for its simplicity and cost-effectiveness. The study involved 55 patients, ...
The MarketWatch News Department was not involved in the creation of this content. RAHWAY, N.J., July 9, 2025 /PRNewswire/ -- Multiple myeloma is a cancer of the plasma cells in which abnormal plasma ...
On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access. In ...
RAHWAY, N.J., March 6, 2025 /PRNewswire/ -- A sinus infection, known as sinusitis, is one of the most common medical conditions. But in some cases, it can come with dangerous complications. In a new ...
REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain ...
Hosted on MSN
Piper Sandler Upgrades Nevro (NVRO)
Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to Neutral. Analyst Price Forecast Suggests 37.44% Upside As of January 28, 2025, ...
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device ...
Globus Medical Inc. reported it is buying Nevro Corp. in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of both companies, Globus will acquire ...
REDWOOD CITY, Calif., Jan. 21, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback